<DOC>
	<DOCNO>NCT00990392</DOCNO>
	<brief_summary>The purpose study determine overall central venous catheter relate infection rate reduce application Polysporin Triple Therapy ointment insertion site .</brief_summary>
	<brief_title>Topical Antibiotics Prevention Intensive Care Unit ( ICU ) Central Line Infections</brief_title>
	<detailed_description>Previous study dialysis population find reduction local system central venous catheter relate infection application topical antibiotic insertion point . One study find mortality benefit Polysporin Triple Therapy ointment . We intend determine preparation reduce overall line infection rate ICU environment application time line insertion twice follow week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<mesh_term>Gramicidin</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>patient admit ICU require central venous catheter previous line infection ICU stay CVC hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Blood stream infection</keyword>
	<keyword>Catheter relate infection</keyword>
	<keyword>Central venous catheter relate infection</keyword>
	<keyword>Line sepsis</keyword>
	<keyword>Topical antibiotic</keyword>
	<keyword>Bacitracin</keyword>
	<keyword>Polymixin</keyword>
	<keyword>Gramicidin</keyword>
	<keyword>Polysporin Triple Therapy</keyword>
	<keyword>Intensive care unit</keyword>
</DOC>